Abstract. The Chinese medicinal herb Sorbaria sorbifolia, native to Changbai Mountain, can induce apoptosis in HepG-2 cells. We studied the mechanism by which 5, 2' , 4'-trihydroxy-6,7, 5'-trimethoxyflavone (TTF1) isolated from acetic ether extracts of Sorbaria sorbifolia induces apoptosis in HepG-2 cells. The results showed that TTF1 both inhibited cell growth and induced apoptosis. RT-PCR and Western blot analysis showed that TTF1 treatment led to decreased transcription and protein expression of bcl-2 and an increase in bax, . These results together suggest that TTF1 may induce apoptosis of HepG-2 cells through a mitochondrial pathway.
Introduction
Mitochondria are the most important cellular organelles, and changes in their function are closely associated with cell apoptosis. Many factors can induce mitochondrial injury and apoptosis, including signaling through receptors, release of pro-apoptosis factors, over-production of reactive oxygen species, obstacles to energy production and calcium imbalance in the cytosol. Studies have shown that certain gene products related to apoptosis located in mitochondria can lead to enlargement of the mitochondrial membrane and the release of many proteins, such as Cyt-c, Smac/DIBLO, AIF and Omi/ HtrA2. The BCL-2 protein family plays an important role in the regulation of apoptosis. Anti-apoptosis and pro-apoptosis proteins can induce the release of Cyt-c by changing the permeability of the mitochondrial membrane. An apoptosome complex then forms through the binding of Cyt-c and Apaf-1 (apoptotic protease activating factor 1), Pro-caspase-9, and dATP. The apoptosome complex dimer then activates caspase-9 and further activates caspase-3, which may next degrade centrosome DNA by DNase activity to induce apoptosis (1) (2) (3) . Finding a component in Chinese herbal medicine which can effectively induce apoptosis is an important area in anti-tumor research within Chinese medicine (4) (5) (6) . Sorbaria sorbifolia (SS) is rosaceous plant which grows extensively in Changbai Mountain in Yunnan, Guizhou, Sichuan, Hubei, Gansu and Ningxia Provinces. It is used to help with activating blood, dissolving stasis, reducing swelling and easing pain, and healing fractures and injuries from falls. We previously reported that the acetic ether extracts of SS inhibited the growth of HepG-2 cells (7) and mouse S180 sarcoma and downregulated the levels of TNF-α, IL-2 and the cellular activity of NK cells (8) . In addition, it inhibited the formation of a positive focus in precancerous rat hepatoma GST-P and down-regulated the expression of p53 and Bcl-2. It increased the activity of SOD and GSH-Px and decreased NOS activity and MDA and NO content (9, 10) . The following six chemicals were identified in the SS extracts: 5,2',4'-trihydroxy-6,7, 5'-trimethoxyflavone (TTF1), 5,7-dihydroxy-8-methoxyflavone, rutin, quercetin, daucosterol, benzoate and p-hydroxybenzoic acid. TTF1 was the first monomeric compound identified from SS (11) . Through electron-microscope scanning, transmission electron-microscopy and DNA eletrophoresis, we observed that the acetic ether extracts of SS-induced apoptosis in HepG-2 cells. The primary component effecting apoptosis was TTF-1, but its mechanism is still not known. This study focuses on the mechanism of TTF1-induced apoptosis of HepG-2 cells through a mitochondrial pathway.
Materials and methods
Extraction of TTF1. TTF1 was separated using the water extraction and alcohol precipitation (WAE) method on 10 kg SS (collected from Jilin Province) as previously described (8) .
Cell culture. The HepG-2 cell line was purchased from KeyGEN Co., Ltd. (Nanjing, China). Cells were grown in RPMI-1640 supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/l streptomycin. Cells were cultured at 37˚C in a humidified incubator containing 5% CO 2 . Cells in the logarithmic growth phase were used for tests.
MTT assay of the cell growth inhibition rate. Cells were seeded in a 96-pore plate at an initial concentration of 1x10 6 /l. Cells were treated with different concentration of TTF1 (25, 50, 100, 200, or 400 µmol/l) with five replicates for each concentration. The positive control contained 5 µmol/l adriamycin (ADR, Wanle Pharmaceutics, Shenzhen, China), and a negative control was also included. After culturing for 24, 48 or 72 h, 20 µl of 5 g/l MTT was added to each well and culturing continued for 4 h. The supernatant of each well was removed and 150 µl of DMSO was added. After shaking the plate for 15 min, the optical density of wells was measured at a wavelength of 490 nm with a microplate reader (Bio-Rad, USA). The inhibition rate was calculated as follows: IR (%) = (1-optical density of the control sample/optical density of the experimental sample) x100%. The IC 50 was also calculated.
Flow cytometry (FCM) apoptosis analysis. HepG-2 cells were seeded at an initial concentration of 1x10 6 /l in a 6-well plate. After culturing for 24 h, cells were treated with 50 or 100 µmol/l TTF1. ADR (5 µmol/l) was used as a positive control, and a negative control was also included. Cells were collected after 48 h by centrifuging at 1000 x g for 5 min and washed twice with phosphate-buffered saline (PBS). Cells were suspended with 200 µl binding buffer, and then 10 µl Annexin V-FITC, and 5 µl protein inhibitor (PI) were added before incubation in the dark for 30 min. Binding buffer (300 µl) was then added, and apoptosis was analyzed using FCM (model, FACSCalibur, USA) and ModfitLT3.0 software.
ELISA for DNA assessment during apoptosis. Cells were cultured for 48 h. The OD value of DNA fragments was assayed using an apoptosis testing kit (Roche, USA). The results were calculated as the OD value of the experimental sample/the OD value of the control.
Observation of apoptosis using transmission electron microscopy. Cells were cultured for 48 h and centrifuged at 1000 x g for 5 min. The cell pellet was collected and fixed with 4 mg/l glutaraldehyde for 2 h and then treated with 1 mg/l osmic acid for 30 min. Cells were dehydrated gradually with ethanol and covered with epoxy resin. The cells were sliced to a thickness of 50 nm. After staining with uranyl acetate and lead citrate, apoptosis was observed using a transmission electron microscope.
Immunohistochemistry for bcl-2 and bax. Cells were cultured for 48 h and the expression levels of bcl-2 and bax were analyzed by immunohistochemistry using mouse anti-human bcl-2 and bax antibodies (Boshide Biotechnology Company, Wuhan, China). The highest density of positive cells was analyzed with photography of the physical cells in true colors. Five statistical fields were chosen for each treatment condition, and the mean was calculated as the positive expression rate of genes related to apoptosis.
RT-PCR for mRNA analysis of bcl-2, bax, Cyt-c, caspase-3 and caspase-9. After culture for 48 h, total cellular RNA was extracted using TRIzol reagent (KeyGEN Co., Ltd.) and the first strand of cDNA was synthesized. The primers for PCR used were as follows: bcl-2 sense primer: 5'-GTGGAGGA GCTCTTCAGGGA-3', anti-sense primer: 5'-AGGCACCC AGGGTGATGCAA-3', product: 304 bp; bax sense primer: 5'-GGCCCACCAGCTCTGAGCAGA -3', anti-sense primer: 5'-GCCACGTGGGCGTCCCAAAGT-3', product: 477 bp; Cyt-c sense primer: 5'-TGAAGCCGCTCGCAAGACTCC-3' , 95˚C for 35 sec, 56˚C for 35 sec, 72˚C for 35 sec; 28 cycles and 72˚C for 10 min. PCR product (5 µl) was loaded for 1% gel electrophoresis (Kaiji Biotechnology Company, Nanjing, China). β-actin was used as an internal control. The results were semi-quantified using the UVP gel photograph analyzing system (Bio-Rad) and Quantity One software (Bio-Rad).
Western blot analysis of bcl-2, bax, Cyt-c, caspase-3 and caspase-9. After culturing for 48 h, cells were collected and the total proteins were extracted using RIPA lysis buffer. The protein concentration was measured using the BCA method. Protein (70 µg) was separated by 10% SDS-PAGE electrophoresis and then transferred to a PVDF membrane (Pall Corporation, Port Washington, NY, USA). The membrane was blocked with 5% milk for 1 h and then incubated at 4˚C overnight with the primary antibody (mouse anti-human bcl-2, bax, Cyt-c, caspase-3 or caspase-9) at a 1:400 dilution. The membrane was washed four times with TBST and then incubated with the HRP-conjugating secondary antibody at a concentration of 1:5000 for 1 h. After washing four times with TBST, the membrane was developed with BeyoECL Plus. The densitometry of the band was analyzed using a UVP gel photograph analyzing system and the relative expression levels of bcl-2, bax, Cyt-c, caspase-3 and caspase-9 were calculated.
Statistical analysis. Data in all experiments are shown as mean ± SD. Statistical difference was evaluated using a one-way ANOVA and independent t-test of sample pairs with SPSS 13.0 software.
Results
Observation of apoptosis using transmission electron microscopy. After treatment with TTF1 ( Fig. 1) and ADR (data not shown), cells were shrunken and the cytosol was condensed. The nuclear chromosomes formed a crescent in the nuclear membrane, suggesting partial damage to the membrane and the appearance of nuclear fragment which was condensed and lacking microvilli. There were intact chromosomes, a large nucleolus, a full membrane and many micro-filaments on the cell surface in the control group (Fig. 2) .
TTF1-inhibited cell growth of HepG-2.
The MTT assay showed that TTF1 inhibited the growth of HepG-2 cells in a time-and dose-dependent manner (Fig. 3) . The inhibitive effect . Western blot analysis to determine the protein levels of bcl-2, bax, Cyt-c, caspase-3 and caspase-9. (A) HepG-2 Cells were treated with different concentrations of TTF1 (sTTF1, 50 µmol/l; lTTF1, 100 µmol/l), ADR (5 µmol/l) and Con (control group cells were treated with normal saline using the same volume as TTF1 treatment) at 48 h. Cells from each group were lysed using RIPA buffer and then were subjected to SDS-PAGE (70 µg/well). Western blot analysis was performed to detect the protein levels of bcl-2, bax, Cyt-c caspase-3 and caspase-9. The intensity of the bcl-2, bax, Cyt-c caspase-3 and caspase-9 protein bands was determined and normalized with actin's intensity using the UVP imager and is plotted in (B). Quantitative real-time PCR was performed to determine the mRNA expression levels of bcl-2, bax, Cyt-c, caspase-3 and caspase-9 as shown in (C and D). 
TTF1-induced apoptosis in
HepG-2 cells. FACS analysis showed an apoptotic peak after TTF1 treatment of HepG-2 cells. The apoptotic cell number increased after TTF1 treatment compared to the negative control and was significantly different (P<0.05) (Fig. 4A and B) . ELISA results showed that DNA fragmentation was higher compared to the negative control and was significantly different (P<0.05) (Fig. 4C) . These results together suggest that TTF1 induced apoptosis in HepG-2 cells.
Immunohistochemistry of bcl-2 and bax. Both bcl-2 and bax were located in cytosol and were stained dark-yellow (Fig. 5A) . TTF1 treatment induced a decrease in the levels of bcl-2 protein (Fig. 5B) as the number of positive cells decreased (Fig. 5Ab) , while the bax protein levels increased as the number of positive cells increased compared to the control.
The effect of TTF1 on transcription and protein expression of bcl-2, bax, Cyt-c, caspase-3 and caspase-9 in HepG-2 cells.
RT-PCR and Western blot analysis showed that transcription and protein expression of bcl-2 gradually decreased after TTF1 treatment for 48 h in HepG-2 cells, while that of bax, Cyt-c, caspase-3 and caspase-9 increased (Fig. 6 ). This suggests that TTF1 may induce apoptosis of HepG-2 cells through a mitochondrial pathway.
Discussion
We found that TTF1 inhibited the growth of HepG-2 cells in a time-and dose-dependent manner. The IC 50 of TTF1 on HepG-2 cells for 24, 48 and 72 h was 208.7, 101.7, 96.7 µmol/l, respectively. We chose 0.5 IC 50 and IC 50 as the concentrations in our experiments and cells were treated for 48 h at these levels in the subsequent study.
Apoptosis is programmed cell death, and the mitochondrial pathway is one of the important pathways that induce apoptosis. Functional changes in mitochondria are closely associated with apoptosis. Mitochondrial injury can be mediated by the mitochondrial membrane. The opening of transfer pores on the mitochondrial membrane leads to the release of many substances, including Cyt-c, Smac/DIABLO, Omi/HtrA2 (a pro-apoptosis factor), and nucleic acid endonuclease G. Among all these components, Cyt-c is thought to be the key factor in apoptosis (11) (12) (13) . The release of Cyt-c is regulated through non-specific damage to the mitochondrial outer membrane and the formation of transfer channels for Cyt-c. The Bcl-2 family also plays an important role in the release of Cyt-c; its main effect is the inhibition of Cyt-c release through the formation of dimers between the BH3 domain of bcl-2 and other anti-apoptosis proteins. Bax is a pro-apoptosis protein and is transferred to the mitochondrial membrane to destroy mitochondrial function and release Cyt-c. Then, the apoptosome complex is formed by the binding of Cyt-c, Apaf-1, Pro-caspase-9 and dATP. The dimer complex activates caspase-9 and further activates caspase-3 (3, (14) (15) (16) .
FACS analysis showed that TTF1 induced apoptosis in HepG-2 cells and that the apoptotic cell number increased as the dose increased. RT-PCR and Western blot analysis showed that the transcription and protein expression of bcl-2 was inhibited, while that of bax, Cyt-c, caspase-3 and caspase-9 increased. Therefore, we propose that TTF1 may destroy mitochondrial integrity and induce the release of Cyt-c. The activation of caspase-9 and further activation of caspase-3 may then induce the degradation of chromosomal DNA and apoptosis in HepG-2 cells.
Sorbaria sorbifolia is rosaceous, perennial herbaceous plant. It has anti-tumor effects but does not damage normal cells and is able to increase immunity, so it is a promising source of plant-based medicines (7) . Further study using molecular techniques will focus on the mechanism by which TTF1 induces apoptosis. The relationship between TTF1's physical structure and its effect should be studied, and further structural modification may help us find a new apoptosis inducer with improved curative effect.
